AS601245 is an orally active, selective, ATP competitive JNK (c-Jun NH2-terminal protein kinase) inhibitor. It targets hJNK1, hJNK2, and hJNK3 isoforms and demonstrates significant selectivity over various other protein kinases. This compound exhibits neuroprotective properties and can be used in different in vitro and in vivo studies.
- Orally active, selective, ATP competitive JNK inhibitor
- Exhibits neuroprotective properties
- Shows selectivity over c-src, CDK2, c-Raf, and other Ser/Thr- and Tyr-protein kinases
- Synergistic effects with Clofibrate in CaCo-2 colon cancer cells
- Provides significant protection against delayed loss of hippocampal CA1 neurons in gerbil models of transient global ischemia
- Potent inhibitor of LPS-induced TNF-α release in mice